Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Acta Neurologica Scandinavica, Supplementum

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ane.12044PMID 23190286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary Immunodeficiency Diseases

  2015cited by this paper
• Effect of Anti-Epileptic Drugs on Serum Level of IgG Subclasses

  2010cited by this paper
• Pancytopenia Associated with Levetiracetam Treatment

  2009cited by this paper
• Serum immunoglobulins and risk of infection: how low can you go?

  2009influential reference
• Reversible panhypogammaglobulinemia associated with the antiepileptic agent levetiracetam.

  2008cited by this paper
• Common variable immunodeficiency: a review

  2004cited by this paper
• Lamotrigine-induced common variable immune deficiency

  2004cited by this paper
• The reversibility of phenytoin-induced IgA deficiency

  2004cited by this paper
• Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood

  2003cited by this paper
• Reversible Panhypogammaglobulinemia Associated with Phenytoin Treatment

  2002cited by this paper
• Secondary hypogammaglobilinemia after use of carbamazepine: case report and review.

  2001cited by this paper
• Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies.

  1999cited by this paper
• The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents

  1999cited by this paper
• A Dysbalanced Immune System in Cryptogenic Lennox‐Gastaut Syndrome

  1995cited by this paper
• Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.

  1994cited by this paper
• Immunological studies in focal epilepsy

  1988cited by this paper
• Mentally incapable adults: consent to treatment.

  1987cited by this paper
• Carbamazepine effects on mononuclear blood cells in epileptic patients

  1986cited by this paper
• The effect of carbamazepine on serum immunoglobulin concentrations

  1982cited by this paper
• IgA deficiency, epilepsy, and hydantoin medication.

  1976cited by this paper
• Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.

  1975cited by this paper
• Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

  1971cited by this paper

• Immunodeficiencies in Adults: Key Considerations for Diagnosis and Management

  2025cites this paper
• Effects of Levetiracetam Treatment on Hematological and Immune Systems in Children: A Single-Center Experience

  2025cites this paper
• Exploring the Smoking-Epilepsy Nexus: a systematic review and meta-analysis of observational studies

  2024cites this paper
• Identification of Candidate Protein Biomarkers Associated with Domoic Acid Toxicosis in Cerebrospinal Fluid of California Sea Lions (Zalophus californianus)

  2024cites this paper
• Deficiency of Interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments

  2024cites this paper
• Associations between antiepileptic use and hypogammaglobulinaemia: findings from a population-based case-control study using data linkage

  2022influential citation
• Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting.

  2022cites this paper
• Determinants and Reference Ranges of Serum Immunoglobulins in Middle-Aged and Elderly Individuals: a Population-Based Study

  2021cites this paper
• Lamotrigine effects on immune gene expression in larval zebrafish.

  2021cites this paper
• Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein.

  2021cites this paper
• Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy

  2021cites this paper
• Association between antiseizure medication use and risk of urinary tract infection: A case-control study.

  2020cites this paper
• Tonsillar granuloma associated with hypogammaglobulinemia

  2020cites this paper
• Effects of perampanel add-on therapy on immunoglobulin levels in pediatric patients with epilepsy.

  2020cites this paper
• Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations

  2020cites this paper
• Secondary Hypogammaglobulinemia: An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation.

  2019cites this paper
• MicroRNAs as Potential Biomarkers for Childhood Epilepsy

  2019cites this paper
• B cell aplasia and hypogammaglobulinemia associated with levetiracetam

  2018cites this paper
• Effect of lamotrigine on in vivo and in vitro cytokine secretion in murine model of inflammation.

  2018cites this paper
• Evaluation of immunomodulatory effects of lamotrigine in BALB/c mice

  2017cites this paper
• Antiepilepsy drugs and the immune system.

  2016cites this paper
• Immunoglobulin A deficiency following treatment with lamotrigine.

  2016cites this paper
• Comorbidity and Childhood Epilepsy: A Nationwide Registry Study

  2016cites this paper
• New diagnostic criteria could distinguish common variable immunodeficiency disorder from anticonvulsant‐induced hypogammaglobulinemia

  2015cites this paper